Assessment of measurable residual disease (MRD) in adult patients with acute lymphocytic leukemia: best use and a case report. Clinical advances in hematology & oncology : H&O Muffly, L. 2020; 18 Suppl 9 (3): 10-14

View details for PubMedID 33843878